NCT00420381 2020-12-19
Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer
Eli Lilly and Company
Phase 2 Completed
Clinical Trials
4 trialsNCT00309140 2020-06-26
An Open Label Study of Oral Enzastaurin in Participants With Cancer
Eli Lilly and Company
Phase 2 Completed
NCT00108056 2019-12-05
Enzastaurin to Treat Recurrent Brain Tumor
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT01445119 2013-08-28
A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas
Eli Lilly and Company
Phase 1 Completed